相似文献
1
Cross-Species Genomics Identifies TAF12, NFYC, and RAD54L as Choroid Plexus Carcinoma Oncogenes.
Cancer Cell. 2015 May 11;27(5):712-27. doi: 10.1016/j.ccell.2015.04.005.
2
Concurrent Gain of Oncogenes Drives Choroid Plexus Carcinoma.
Cancer Discov. 2015 Jul;5(7):OF26. doi: 10.1158/2159-8290.CD-RW2015-096. Epub 2015 May 21.
3
A new genetically engineered mouse model of choroid plexus carcinoma.
Biochem Biophys Res Commun. 2018 Feb 5;496(2):568-574. doi: 10.1016/j.bbrc.2017.11.192. Epub 2018 Jan 12.
4
TP53 alterations determine clinical subgroups and survival of patients with choroid plexus tumors.
J Clin Oncol. 2010 Apr 20;28(12):1995-2001. doi: 10.1200/JCO.2009.26.8169. Epub 2010 Mar 22.
5
Comparative Cytogenetic Analysis of Dog and Human Choroid Plexus Tumors Defines Syntenic Regions of Genomic Loss.
J Neuropathol Exp Neurol. 2018 May 1;77(5):413-419. doi: 10.1093/jnen/nly020.
6
Myc and Loss of p53 Cooperate to Drive Formation of Choroid Plexus Carcinoma.
Cancer Res. 2019 May 1;79(9):2208-2219. doi: 10.1158/0008-5472.CAN-18-2565. Epub 2019 Mar 18.
7
Choroid plexus tumors in children.
Neurosurg Clin N Am. 2003 Oct;14(4):621-31. doi: 10.1016/s1042-3680(03)00058-5.
8
Molecular characterization of choroid plexus tumors reveals novel clinically relevant subgroups.
Clin Cancer Res. 2015 Jan 1;21(1):184-92. doi: 10.1158/1078-0432.CCR-14-1324. Epub 2014 Oct 21.
9
High-resolution genomic analysis does not qualify atypical plexus papilloma as a separate entity among choroid plexus tumors.
J Neuropathol Exp Neurol. 2015 Feb;74(2):110-20. doi: 10.1097/NEN.0000000000000154.
10
Alternative lengthening of telomeres is enriched in, and impacts survival of TP53 mutant pediatric malignant brain tumors.
Acta Neuropathol. 2014 Dec;128(6):853-62. doi: 10.1007/s00401-014-1348-1. Epub 2014 Oct 15.
引用本文的文献
1
Single-nucleus RNA-seq dissection of choroid plexus tumor cell heterogeneity.
EMBO J. 2024 Dec;43(24):6766-6791. doi: 10.1038/s44318-024-00283-2. Epub 2024 Oct 31.
2
Choroid Plexus Pathophysiology.
Annu Rev Pathol. 2025 Jan;20(1):193-220. doi: 10.1146/annurev-pathmechdis-051222-114051. Epub 2025 Jan 2.
3
Activation of Wnt/β-catenin signaling is critical for the tumorigenesis of choroid plexus.
Neuro Oncol. 2025 Jan 12;27(1):106-122. doi: 10.1093/neuonc/noae176.
4
SJPedPanel: A Pan-Cancer Gene Panel for Childhood Malignancies to Enhance Cancer Monitoring and Early Detection.
Clin Cancer Res. 2024 Sep 13;30(18):4100-4114. doi: 10.1158/1078-0432.CCR-24-1063.
5
Marrow-ablative consolidation chemotherapy and molecular targeted therapy delivered in a risk-adapted manner for newly diagnosed children with choroid plexus carcinoma: .
Neurooncol Adv. 2024 Jul 5;6(1):vdae109. doi: 10.1093/noajnl/vdae109. eCollection 2024 Jan-Dec.
6
Comprehensive multiomics analysis reveals distinct differences between pediatric choroid plexus papilloma and carcinoma.
Acta Neuropathol Commun. 2024 Jun 12;12(1):93. doi: 10.1186/s40478-024-01814-y.
7
Characterization of a G2M checkpoint-related gene model and subtypes associated with immunotherapy response for clear cell renal cell carcinoma.
Heliyon. 2024 Apr 5;10(7):e29289. doi: 10.1016/j.heliyon.2024.e29289. eCollection 2024 Apr 15.
8
HMGB1 promotes mitochondrial transfer between hepatocellular carcinoma cells through RHOT1 and RAC1 under hypoxia.
Cell Death Dis. 2024 Feb 20;15(2):155. doi: 10.1038/s41419-024-06536-6.
9
Approaches to Minimise the Neurodevelopmental Impact of Choroid Plexus Carcinoma and Its Treatment.
Life (Basel). 2023 Sep 1;13(9):1855. doi: 10.3390/life13091855.
10
Pan-Cancer Analysis of Oncogenic Role of RAD54L and Experimental Validation in Hepatocellular Carcinoma.
J Inflamm Res. 2023 Sep 11;16:3997-4017. doi: 10.2147/JIR.S426558. eCollection 2023.
本文引用的文献
1
Molecular characterization of choroid plexus tumors reveals novel clinically relevant subgroups.
Clin Cancer Res. 2015 Jan 1;21(1):184-92. doi: 10.1158/1078-0432.CCR-14-1324. Epub 2014 Oct 21.
2
Recurrent somatic structural variations contribute to tumorigenesis in pediatric osteosarcoma.
Cell Rep. 2014 Apr 10;7(1):104-12. doi: 10.1016/j.celrep.2014.03.003. Epub 2014 Apr 3.
3
C11orf95-RELA fusions drive oncogenic NF-κB signalling in ependymoma.
Nature. 2014 Feb 27;506(7489):451-5. doi: 10.1038/nature13109. Epub 2014 Feb 19.
4
Rad54 functions as a heteroduplex DNA pump modulated by its DNA substrates and Rad51 during D loop formation.
Mol Cell. 2014 Feb 6;53(3):420-32. doi: 10.1016/j.molcel.2013.12.027. Epub 2014 Jan 30.
5
Choroid plexus carcinomas are characterized by complex chromosomal alterations related to patient age and prognosis.
Genes Chromosomes Cancer. 2014 May;53(5):373-80. doi: 10.1002/gcc.22148. Epub 2014 Jan 30.
6
The choroid plexus and cerebrospinal fluid: emerging roles in development, disease, and therapy.
J Neurosci. 2013 Nov 6;33(45):17553-9. doi: 10.1523/JNEUROSCI.3258-13.2013.
7
Cross-species array comparative genomic hybridization identifies novel oncogenic events in zebrafish and human embryonal rhabdomyosarcoma.
PLoS Genet. 2013 Aug;9(8):e1003727. doi: 10.1371/journal.pgen.1003727. Epub 2013 Aug 29.
8
Signatures of mutational processes in human cancer.
Nature. 2013 Aug 22;500(7463):415-21. doi: 10.1038/nature12477. Epub 2013 Aug 14.
9
ATM- and ATR-mediated phosphorylation of XRCC3 regulates DNA double-strand break-induced checkpoint activation and repair.
Mol Cell Biol. 2013 May;33(9):1830-44. doi: 10.1128/MCB.01521-12. Epub 2013 Feb 25.
10
Sequence-specific transcription factor NF-Y displays histone-like DNA binding and H2B-like ubiquitination.
Cell. 2013 Jan 17;152(1-2):132-43. doi: 10.1016/j.cell.2012.11.047.
Zotero 插件